Posted on 11월 3, 202211/3/22
Payer Oncology Access Management in 2022
Posted on 10월 17, 202210/17/22
Developing Best-in-class Copay Programs for Gross-to-Net
Posted on 10월 12, 202210/12/22
Benchmarking Your Specialty Brand’s Rx Pull-Through Against Competitors In and Out of Your Network
Posted on 9월 2, 20229/2/22
Plasma derived medicinal products – What is the way forward?
Posted on 8월 2, 20228/2/22
How to Ensure Speed and Efficiency When Launching in Canada
Posted on 7월 27, 20227/27/22
Commercialization Strategies in Oncology — The Right Partner Can Reduce Risk and Boost Rewards
Posted on 6월 29, 20226/29/22
An Innovative Approach to Comprehensive Key Opinion Leader (KOL) Mapping
Posted on 5월 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Posted on 4월 20, 20224/20/22